AKT1 and prostate carcinoma: The role of DHEA in prostate cancer progression remains controversial as DHEA has also been shown to stimulate prostate cancer proliferation and PSA expression in prostate cancer models in vitro and in vivo (49, 50) via PI3K/Akt signaling.